Harry R Büller, Martin H Prins. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Anticoagulants/administration & dosageDrug Administration ScheduleHumansPulmonary Embolism/prevention & controlSecondary PreventionVenous Thrombosis/prevention & controlVitamin K/antagonists & inhibitorsWarfarin/administration & dosage
Substances: See more » AnticoagulantsVitamin KWarfarin
Year: 2003 PMID: 12917308 DOI: 10.1056/NEJMe038112
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245